iSpecimen Inc. Files 8-K with Corporate Updates

Ticker: ISPC · Form: 8-K · Filed: 2025-07-10T00:00:00.000Z

Sentiment: neutral

Topics: corporate-filing, bylaws, financials

TL;DR

iSpecimen filed an 8-K for corporate changes and financials.

AI Summary

On July 9, 2025, iSpecimen Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws and the filing of Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Woburn, MA, and operates in the commercial physical & biological research sector.

Why It Matters

This filing indicates corporate housekeeping and the submission of financial information, which is crucial for investors to stay updated on the company's formal structure and financial status.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial events or strategic shifts that would inherently increase risk.

Key Players & Entities

FAQ

What specific amendments were made to iSpecimen Inc.'s Articles of Incorporation or Bylaws?

The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text of the 8-K.

What type of financial statements were filed with this 8-K?

The filing states that 'Financial Statements and Exhibits' were filed, but does not specify the period or type (e.g., quarterly, annual) of these statements.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 9, 2025.

What is iSpecimen Inc.'s primary business sector?

iSpecimen Inc. operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, with SIC code 8731.

Where are iSpecimen Inc.'s principal executive offices located?

iSpecimen Inc.'s principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.

From the Filing

0001213900-25-062804.txt : 20250710 0001213900-25-062804.hdr.sgml : 20250710 20250710163031 ACCESSION NUMBER: 0001213900-25-062804 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250709 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250710 DATE AS OF CHANGE: 20250710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 251116614 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 ea0248396-8k_ispecimen.htm CURRENT REPORT false --12-31 0001558569 0001558569 2025-07-09 2025-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): July 9, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road , Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.   On July 9, 2025, iSpecimen Inc. (the “Company”) amended its Second Amended and Restated Bylaws (the “Bylaws”) to modify the quorum requirement for shareholder meetings. The amendment reduced the quorum threshold from a majority of the voting power of the Company’s outstanding shares entitled to vote at a meeting to 34% of such voting power. A copy of the Bylaws is filed as Exhibit 3.1 and incorporated

View on Read The Filing